Categorías
-
Adhesives
6
Amines
115
Amino Acids
210
Analytical Reagents
751
Antibiotics
275
Bioactive Small Molecules
806
Aroma Chemicals
247
Biochemicals
1158
Boronic Acids
4
Buffers
105
Building Blocks
2196
Carbohydrates
193
Catalysts
120
Chiral Compounds
77
Coccus nucifera oil
0
Detergents
63
Diagnostic Raw Materials
273
Flavours and Fragrance Materials
236
Fluorinated Products
68
Furans
7
Gases in Solution
53
Grignard Reagents
32
HPLC Reagents
8
Imidazoles
19
Indoles
48
Inorganic Chemicals
360
Ion-Pair Reagents
21
Ligands
81
Organics
1651
Oxazoles
3
Peptide Reagents
102
Phenols
55
Picolines
0
Piperazines
13
Pyrazines
3
Pyridines
69
Pyrimidines
36
Quaternary Ammonium salts
45
Reagents
114
Research Organics & Inorganics
895
Salts
311
Sealing Compounds
1
Sherclin
1
Solvents
134
Stains & Indicators
324
Sugars
67
Tailor-made solutions
1
Testing Standards
4
Uncategorised
23
Water Analysis
12
Cephalosporin C sodium salt
(90023326 | 51762-04-0)
CAS: | 51762-04-0 |
---|---|
Fórmula molecular: | C16H20N3NaO8S |
Peso molecular: | 437.40 |
Disponibilidad: | En stock |
---|---|
Descargas: | Especificaciones del producto | Ficha de datos de seguridad [EN] |
90023326-1g | 1g | £93.30 | |
Pedido bulk |
90023326-1g | 1g | €130.70 | |
Pedido bulk |
90023326-1g | 1g | $140.00 | |
Pedido bulk |
Ficha de datos de seguridad
Certificado de análisis
Detalle del producto
Product Code | 90023326 | ||||
Product Name | Cephalosporin C sodium salt | ||||
Categories | Antibiotics Bioactive Small Molecules Research Organics & Inorganics | ||||
CAS | 51762-04-0 | ||||
Molecular Formula | C16H20N3NaO8S | ||||
Molecular Weight | 437.40 | ||||
Storage Details | 2 to 8 °C | ||||
Harmonised Tariff Code | 29411000 |
Especificaciones del producto
Flash Point | 446.5 Deg C | ||||
Water | <0.3% | ||||
Assay | >99% | ||||
Optical Rotation | (a)D20+103 (H20) | ||||
Appearance | White powder | ||||
Vapour Pressure | 3.38E-29mmHg @ 25 Deg C |
Información de seguridad
Pictograms |
|
||||
Signal word | danger | ||||
Hazard statements |
|
||||
Precautionary statements |
|